Beschreibung
Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.
Figure 25
ChartSource Paper
Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled …Cite This Figure
![Figure 25: Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.]() > Source: Poonkiat Suchonwanit et al. "Low-level laser therapy for the treatment of androgenetic alopecia in Thai men a." *Lasers in medical science*, 2019. PMID: [30569416](https://pubmed.ncbi.nlm.nih.gov/30569416/)
<figure> <img src="" alt="Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups." /> <figcaption>Figure 25. Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.<br> Source: Poonkiat Suchonwanit et al. "Low-level laser therapy for the treatment of androgenetic alopecia in Thai men a." <em>Lasers in medical science</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30569416/">30569416</a></figcaption> </figure>